Trials / Conditions / Pulmonary Inflammation
Pulmonary Inflammation
5 registered clinical trials studyying Pulmonary Inflammation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Impr NCT04433546 | PhaseBio Pharmaceuticals Inc. | Phase 2 |
| Terminated | A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic NCT03309358 | Synspira, Inc. | Phase 1 |
| Unknown | Pulmonary and Systemic Effects of Exposure to Wood Smoke NCT03302117 | Umeå University | — |
| Terminated | Modulation of Intestinal and Pulmonary Inflammation by Lactobacillus Diet Supplementation in Pediatric Cystic NCT01837355 | Cantonal Hospital of St. Gallen | N/A |
| Completed | Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 NCT01748838 | Celtaxsys, Inc. | Phase 1 |